|
Feb 17
|
GlaxoSmithKline Pharmaceuticals Ltd (BOM:500660) Q3 2025 Earnings Call Highlights: Strong ...
|
|
Feb 15
|
GSK shares shorted by leading U.S. hedge fund, The Times reports
|
|
Feb 15
|
Here's Why We're Wary Of Buying GSK's (LON:GSK) For Its Upcoming Dividend
|
|
Feb 14
|
Hedge fund Citadel takes short position in GSK, FT reports
|
|
Feb 13
|
ViiV Healthcare and the pan-Canadian Pharmaceutical Alliance (pCPA) successfully finalize negotiations for APRETUDE for HIV-1 Pre-Exposure Prophylaxis
|
|
Feb 12
|
Some May Be Optimistic About GSK's (LON:GSK) Earnings
|
|
Feb 11
|
Goldman Sachs Turns Bearish On Vaccine Maker Dynavax Amid Shingles And Hepatitis B Uncertainty
|
|
Feb 10
|
Recent uptick might appease GSK plc (LON:GSK) institutional owners after losing 7.8% over the past year
|
|
Feb 6
|
Bear Of The Day: GSK PLC (GSK)
|
|
Feb 6
|
Kratos Defense and GSK have been highlighted as Zacks Bull and Bear of the Day
|
|
Feb 6
|
GSK PLC (GSK) Q4 2024 Earnings Call Highlights: Strong Specialty Medicines Drive Growth Amid ...
|
|
Feb 6
|
The most popular stocks and funds for investors in January
|
|
Feb 6
|
Why GSK plc (GSK) Went Up on Wednesday
|
|
Feb 5
|
GSK Surges 8% After Bumping Its 2031 Outlook To North Of $50 Billion
|
|
Feb 5
|
GSK Stock Jumps on Long-Term Outlook Boost, $2.5B Share Buyback Plan
|
|
Feb 5
|
Steady M&A Deals to Begin 2025, Disappointing IPOs So Far
|
|
Feb 5
|
GSK Q4 Earnings: Revenue And EPS Beat, Initiates $2.5 Billion Stock Buyback, Raises Long-Term Annual Sales Forecast To Over $50 Billion
|
|
Feb 5
|
GSK lifts long-term sales targets on new drug pipeline
|
|
Feb 5
|
GSK (GSK) Tops Q4 Earnings and Revenue Estimates
|
|
Feb 5
|
GSK Lifts Long-Term Outlook on Drug Pipeline, Buys Back Shares
|